SCHEMBL5576052

SCHEMBL5576052

CNC(=O)C(COC(C)=O)=C(COC(C)=O)COC(C)=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.36
LMNA P02545 1/20 0.36
HSD17B10 Q99714 1/20 0.36
FAAH O00519 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.32
PGR P06401 1/20 0.30
CHRM2 P08172 1/20 0.30
CHRM4 P08173 1/20 0.30
HTR1A P08908 1/20 0.30
CHRM5 P08912 1/20 0.30
CHRM1 P11229 1/20 0.30
CHRNB2 P17787 1/20 0.30
CHRM3 P20309 1/20 0.30
TBXA2R P21731 1/20 0.30
CHRNB4 P30926 1/20 0.30
CHRNA3 P32297 1/20 0.30
CHRNA7 P36544 1/20 0.30
CHRNA4 P43681 1/20 0.30
CHRNA10 Q9GZZ6 1/20 0.30
CHRNA9 Q9UGM1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24091692 0.72 ALDH1A1 (0.37) ALDH1A1LMNAHSD17B10FAAHSMN1; SMN2
SCHEMBL8050961 0.70
SCHEMBL21091354 0.67
SCHEMBL2706963 0.64 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10FAAHSMN1; SMN2
SCHEMBL13793360 0.64 POLB (0.46) ALDH1A1LMNAHSD17B10FAAHSMN1; SMN2
SCHEMBL10530231 0.63 ALDH1A1 (0.53) ALDH1A1LMNAHSD17B10FAAHSMN1; SMN2
SCHEMBL4688208 0.63 ALDH1A1 (0.53) ALDH1A1LMNAHSD17B10FAAHSMN1; SMN2
SCHEMBL311876 0.63 ALDH1A1 (0.53) ALDH1A1LMNAHSD17B10FAAHSMN1; SMN2
SCHEMBL4869307 0.63
SCHEMBL36403 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3246353-B1 USE OF SURFACTANTS TO EXTRACT A PLATINUM GROUP METAL OR GOLD FROM ORGANIC COMPOSITIONS CENTRE NAT RECH SCIENT (FR) 2021-03-17 EP disclosed
US-10752976-B2 Process of extraction of a platinum group metal or gold from organic compositions with surfactants UNIVERSITE DE STRASBOURG (FR) 2020-08-25 US disclosed
US-20190316223-A1 Use of Surfactants to Extract a Platinum Group Metal or Gold from Organic Compositions CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2019-10-17 US disclosed
EP-3458501-A1 USE OF SURFACTANTS TO EXTRACT A PLATINUM GROUP METAL OR GOLD FROM ORGANIC COMPOSITIONS Centre National De La Recherche Scientifique (FR) 2019-03-27 EP disclosed
WO-2017198846-A1 USE OF SURFACTANTS TO EXTRACT A PLATINUM GROUP METAL OR GOLD FROM ORGANIC COMPOSITIONS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2017-11-23 WO disclosed
EP-3246353-A1 USE OF SURFACTANTS TO EXTRACT A PLATINUM GROUP METAL OR GOLD FROM ORGANIC COMPOSITIONS Centre National De La Recherche Scientifique (FR) 2017-11-22 EP disclosed
US-20070275046-A1 Noval Surfactants and Applications Thereof TS PHARMA (FR) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275046-A1 Noval Surfactants and Applications Thereof SGMS1, SGMS2, ANXA6 ALDH1A1 3574/4885LMNA 1160/4885HSD17B10 4214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.